Pediatrics (System-Integrated)

Cow's milk protein allergy in infants

Clinical Overview and When to Suspect Cow's Milk Protein Allergy

— Affects ~2–3% of infants <1 year; most common food allergy in infancy

— Onset typically within first 6 months, often within weeks of introducing formula or, less commonly, via maternal dairy in breast milk

— Natural history favorable: ~50% tolerate by age 1, ~75% by age 3, >90% by age 5 (IgE-mediated cases resolve later than non-IgE)

— IgE-mediated: Rapid onset (minutes–2 hours): urticaria, angioedema, vomiting, wheeze, anaphylaxis

— Non-IgE-mediated (cell-mediated): Delayed (hours–days): proctocolitis, FPIES, enteropathy, GERD-like symptoms, eczema flare

— Mixed: Atopic dermatitis with GI symptoms

— Healthy-appearing breastfed infant with painless, streaky blood/mucus in stool → think allergic proctocolitis

— Formula-fed infant with recurrent vomiting, irritability, poor weight gain, eczema

— Profuse repetitive vomiting 1–4 hours after feed ± lethargy, pallor, hypotension → FPIES (food protein-induced enterocolitis syndrome)

— Urticaria/wheeze immediately after first cow's milk formula bottle

Board pearl: The classic exam vignette is a thriving, breastfed 4–8 week-old with painless bright red streaks of blood in otherwise normal stool and a happy infant — this is allergic proctocolitis until proven otherwise, and the first step is maternal dairy elimination, not endoscopy or stool studies.

Key distinction: Lactose intolerance presents with watery diarrhea/gas without blood, eczema, or hives, and is exceedingly rare in healthy term infants — do not confuse with CMPA on the exam.

Definition: Cow's milk protein allergy (CMPA) is an immune-mediated adverse reaction to bovine milk proteins (casein, β-lactoglobulin, α-lactalbumin), distinct from lactose intolerance (enzymatic, rare in infants).

Epidemiology:

Two immunologic phenotypes — must distinguish:

When to suspect in a Step 3 ambulatory visit:

Risk factors: Family history of atopy, personal eczema, early non-exclusive formula exposure, cesarean delivery (modest association).

Presentation Patterns and Key History

— Well-appearing, thriving infant 1–6 months old

— Streaks of blood and mucus in soft/loose stool

— Often exclusively breastfed (mother consumes dairy) or cow's milk formula-fed

— No vomiting, no growth failure, normal exam

— Chronic non-bloody diarrhea, vomiting, poor weight gain, hypoalbuminemia, anemia

— Mimics celiac disease but at younger age

— Acute form: Profuse, repetitive projectile vomiting 1–4 hours after ingestion, then diarrhea ~5–10 hours; lethargy, pallor, hypotension, can mimic sepsis

— Chronic form: In young formula-fed infants with cumulative exposure → vomiting, diarrhea, FTT, metabolic acidosis

— Afebrile, no urticaria, no respiratory symptoms — this is the key contrast with IgE reactions

— Onset within minutes to 2 hours: urticaria, lip/periorbital angioedema, vomiting, wheeze, stridor, anaphylaxis

— Often first-bottle reaction after weaning from breast milk

— Timing of symptoms relative to feeds (immediate vs delayed)

— Feeding type: exclusive breast, mixed, formula brand (standard vs hydrolyzed vs soy)

— Stool character: blood, mucus, frequency, consistency

— Growth trajectory — review percentiles on the chart

— Family atopy (asthma, eczema, food allergy, allergic rhinitis)

— Prior reactions, ED visits, epinephrine use

Step 3 management: In the outpatient pediatric visit, plot weight, length, and head circumference percentiles at every encounter for a suspected CMPA infant — declining percentiles change management from simple dietary elimination to escalation (allergy/GI referral, hypoallergenic formula, hospitalization for FTT if severe).

Board pearl: FPIES is frequently misdiagnosed as sepsis or gastroenteritis — the tell is symptom onset 1–4 hours after a specific food (often cow's milk or soy formula) with no fever and complete recovery between episodes.

Allergic proctocolitis (most common non-IgE form):

Food protein-induced enteropathy:

FPIES (food protein-induced enterocolitis syndrome):

IgE-mediated CMPA:

Mixed presentation: Moderate-to-severe atopic dermatitis poorly responsive to topicals + GI complaints

Key history points to elicit:

Physical Exam Findings and Hemodynamic Assessment

— Allergic proctocolitis: well-appearing, alert, smiling, normal vitals

— FPIES acute episode: pale, lethargic, mottled, hypotonic, often afebrile

— IgE-mediated reaction: anxious, urticarial, possible respiratory distress

— Tachycardia and hypotension in acute FPIES (10–20% develop shock) or anaphylaxis

— Afebrile is the rule — fever should redirect to infection

— Document weight at every visit; compare to prior growth curve

— Atopic dermatitis in flexural/facial distribution, especially in mixed CMPA

— Acute urticaria, angioedema (lips, eyelids) in IgE reactions

— Perianal erythema/excoriation in protein-induced enteropathy

— Stridor, hoarseness, wheeze, accessory muscle use in IgE-mediated anaphylaxis

— Allergic shiners and Dennie-Morgan lines in chronic atopy

— Usually soft, non-distended in proctocolitis

— Distension, hyperactive bowel sounds during FPIES episode

— Hepatosplenomegaly should prompt alternate workup (metabolic, infectious)

— Capillary refill, mental status, peripheral perfusion

— In FPIES shock: give 20 mL/kg isotonic crystalloid bolus, ondansetron, consider IV methylprednisolone

— In anaphylaxis: IM epinephrine 0.01 mg/kg (max 0.3 mg) into anterolateral thigh — first-line, before antihistamines or steroids

CCS pearl: For a vomiting, pale, hypotonic 5-month-old presenting 2 hours after a feed, your CCS order set is: IV access, NS bolus 20 mL/kg, accucheck, CBC, BMP, blood culture (rule out sepsis), ondansetron IV, continuous monitoring — then take a careful feeding history that reveals recent cow's milk formula challenge.

Board pearl: Normal exam in a thriving infant with isolated blood-streaked stools = allergic proctocolitis; if the infant looks unwell, growth is failing, or there is significant distension, broaden the differential urgently.

General appearance — the most important determinant of acuity:

Vital signs:

Skin:

HEENT / respiratory:

Abdomen:

Rectal exam: Visible streaks of blood/mucus on diaper or rectal exam; no fissures, no mass — fissure suggests alternative diagnosis

Hemodynamic assessment in suspected FPIES or anaphylaxis:

Diagnostic Workup — Initial Labs, Imaging, and Biomarkers

— Severe symptoms, failure to thrive, atypical features, or diagnostic uncertainty

— Pre-referral workup before allergy/GI consultation

— CBC with differential: Iron-deficiency anemia (chronic GI blood loss), eosinophilia (supports allergic etiology, but nonspecific)

— CMP/albumin: Hypoalbuminemia in protein-losing enteropathy

— Stool studies: Occult blood, fecal calprotectin (elevated but nonspecific), stool culture/C. difficile/rotavirus to exclude infection if diarrhea is prominent

— Iron studies and ferritin if anemia present

— Serum specific IgE to cow's milk protein (ImmunoCAP); cutoffs predict reactivity but not severity

— Skin prick testing by allergist — high negative predictive value

— Component-resolved diagnostics (casein, β-lactoglobulin) help predict persistence

— Abdominal radiograph only if obstruction, NEC, or distension suggests surgical pathology

— Avoid CT in infants

— Serum IgG/IgG4 panels to foods — no role, frequently ordered by alternative providers; specifically not endorsed by AAAAI

— Hair analysis, applied kinesiology, electrodermal testing — pseudoscience

— Routine atopy patch testing for cow's milk — limited evidence

Key distinction: A positive specific IgE to milk tells you about sensitization and IgE-mediated risk but is negative or irrelevant in non-IgE CMPA (proctocolitis, FPIES, enteropathy) — never use it to "rule out" these conditions.

Board pearl: Ordering food-specific IgG panels for an infant with eczema and fussiness is a wrong-answer distractor on Step 3 — counsel families that these tests are not validated and may lead to harmful unnecessary dietary restriction.

CMPA is fundamentally a clinical diagnosis confirmed by elimination and reintroduction — labs are adjunctive and often unnecessary in mild non-IgE cases.

When labs are appropriate:

Initial laboratory panel for suspected non-IgE CMPA with concerning features:

For suspected IgE-mediated CMPA:

Imaging: Not routinely indicated.

Tests that are NOT recommended (high-yield negative):

In acute FPIES episode: Neutrophilic leukocytosis, thrombocytosis, metabolic acidosis, occasionally methemoglobinemia in severe cases.

Diagnostic Workup — Confirmatory Studies and Oral Food Challenge

— Step 1: Eliminate cow's milk protein from infant's diet (maternal dairy elimination if breastfed; hydrolyzed/amino-acid formula if formula-fed)

— Step 2: Observe symptom resolution over 2–4 weeks (proctocolitis bleeding typically resolves in 72–96 hours, eczema in 2–4 weeks)

— Step 3: Reintroduce cow's milk protein — recurrence of symptoms confirms diagnosis

— Open OFC acceptable for non-IgE, low-risk cases (often done at home with proctocolitis around 9–12 months)

— Supervised/medically observed OFC for IgE-mediated CMPA, FPIES, or any history of anaphylaxis — performed in allergy clinic with IV access, epinephrine, monitoring

— Double-blind placebo-controlled food challenge (DBPCFC) = research gold standard; rarely needed clinically

— Proctocolitis biopsy (if performed): focal eosinophilic infiltrate in lamina propria (>6–20/HPF)

— Eosinophilic esophagitis: ≥15 eosinophils/HPF

— Serial weight, length, head circumference

— Consider dietitian referral when significant dietary restriction is required

— Mild non-IgE symptoms → trial elimination → reintroduce at 6 months and again at 12 months

— Severe, IgE-mediated, or FPIES → allergist referral, formal challenge before reintroduction

Step 3 management: For a thriving breastfed infant with allergic proctocolitis, advise the mother to eliminate all dairy (and consider soy) for 2–4 weeks; if bleeding resolves and recurs on reintroduction, diagnosis is confirmed — no endoscopy needed. Plan reintroduction trial around 12 months of age.

Board pearl: A negative skin prick test and undetectable specific IgE do not exclude non-IgE CMPA; the clinical elimination–reintroduction trial remains diagnostic regardless of allergy testing results.

Gold standard: Elimination followed by reintroduction — the diagnostic and therapeutic linchpin.

Oral food challenge (OFC):

Endoscopy/biopsy: Reserve for atypical presentations, failure of elimination diet, suspected eosinophilic gastroenteritis, or severe enteropathy.

Documenting growth and nutrition:

Algorithm for the Step 3 examinee:

Risk Stratification and First-Line Management Logic

— Allergic proctocolitis in well-thriving infant

— Mild GERD-like symptoms, mild eczema

— First-line: Dietary elimination, outpatient management, primary care follow-up

— Failure to thrive, hypoalbuminemia, anemia, severe enteropathy, chronic FPIES

— First-line: Extensively hydrolyzed or amino acid formula, GI/allergy referral, possible hospitalization for nutritional rescue

— Any history of urticaria, angioedema, wheezing, or anaphylaxis

— First-line: Strict avoidance, epinephrine auto-injector prescription (0.15 mg for <25 kg), allergy referral, anaphylaxis action plan

— Recognize as non-infectious shock-like picture

— Acute: IV fluids, ondansetron, methylprednisolone, observation

— Long-term: avoid trigger, supervised challenge at 12–18 months by allergist

— Breastfed infant: Continue breastfeeding; mother eliminates dairy (and soy if symptoms persist) — supplement maternal calcium 1000 mg/day and vitamin D 600 IU/day

— Formula-fed infant: First-line is extensively hydrolyzed casein formula (eHF); ~90% tolerate

— eHF failure or severe symptoms: Step up to amino acid–based formula (AAF)

— Soy formula: Acceptable in IgE-mediated CMPA in infants >6 months without concurrent soy allergy; avoid in FPIES and enteropathy (40–50% cross-react)

— Goat/sheep milk formulas: NOT acceptable — extensive cross-reactivity with bovine proteins

Key distinction: In FPIES, soy is co-implicated in up to 50% of cases, so empiric soy formula is the wrong answer — use eHF or AAF instead.

Board pearl: Insurance often requires prior authorization for AAF; documenting failed eHF trial and growth failure is necessary — a Step 3-style health-systems detail.

Stratify by phenotype and severity — this drives the entire management algorithm:

Mild–moderate non-IgE CMPA (most common):

Severe non-IgE CMPA:

IgE-mediated CMPA:

Acute FPIES:

Feeding strategy by category:

Pharmacotherapy and Nutritional Therapy — First-Line Regimens

— Casein- or whey-based, proteins hydrolyzed to <3 kDa peptides

— Examples: Nutramigen, Alimentum, Pregestimil

— First-line for formula-fed infants with CMPA

— Tolerated by ~90% of CMPA infants

— Trial for 2–4 weeks; assess symptom resolution and growth

— Elemental: 100% free amino acids (Neocate, EleCare, PurAmino)

— Indications: eHF failure, severe symptoms, FPIES with FTT, severe atopic dermatitis, multiple food protein intolerance, eosinophilic esophagitis

— More expensive; usually requires prior authorization documentation

— Eliminate all dairy: milk, cheese, yogurt, butter, whey, casein, hidden ingredients

— Read labels for "contains milk" allergen statement

— Maternal supplements: calcium 1000 mg/day, vitamin D 600 IU/day

— Dietitian referral helpful

— IM epinephrine 0.01 mg/kg (1:1000) for anaphylaxis — first-line, no contraindications

— Antihistamines and steroids are adjuncts only, never replace epinephrine

— Ondansetron 0.15 mg/kg IV/IM for FPIES vomiting

— Methylprednisolone 1 mg/kg IV for severe FPIES episode

— Topical steroids/emollients for associated eczema

Step 3 management: When a 2-month-old on standard cow's milk formula has bloody stools, the best next step is to switch to extensively hydrolyzed formula — not soy, not partially hydrolyzed, not amino acid (unless eHF fails).

Board pearl: Probiotics, lactase drops, and "sensitive" formulas are not treatments for CMPA and represent classic wrong-answer distractors.

CMPA is a nutritional-therapy disease, not a pharmacotherapy disease — the "drug" is the formula or maternal diet.

Extensively hydrolyzed formula (eHF):

Amino acid–based formula (AAF):

Soy formula: Acceptable only in IgE-mediated CMPA in infants ≥6 months without soy sensitization; avoid in <6 months, FPIES, enteropathy.

Partially hydrolyzed formula (pHF): NOT therapeutic for CMPA — marketed for "comfort"; do not use to treat allergy.

Maternal dairy elimination (breastfeeding mothers):

Adjunctive pharmacotherapy:

Procedural and Specialty Management Pathways

— Performed in allergy clinic or hospital with monitoring, IV access, emergency medications

— Indications:

— Confirming resolution of IgE-mediated CMPA (usually after age 1, with falling specific IgE)

— Reintroducing food after FPIES (typically 12–18 months symptom-free)

— Diagnostic uncertainty

— Graded dosing: starting at 0.1 mL milk, doubling every 15–30 minutes

— Observation for ≥4 hours after final dose (longer for FPIES, up to 6 hours)

— Treat reactions per anaphylaxis algorithm

— Reserved for atypical or refractory cases, suspected eosinophilic esophagitis/gastroenteritis, IBD differential

— Findings: eosinophilic infiltrate in lamina propria, lymphonodular hyperplasia in proctocolitis

— Anaphylaxis: IM epinephrine 0.01 mg/kg (max 0.3 mg) anterolateral thigh, repeat q5–15 min PRN, IV fluids 20 mL/kg, supine positioning with legs elevated, supplemental O₂, H1/H2 blockers and steroids as adjuncts, observe ≥4–6 hours for biphasic reaction

— FPIES acute episode: IV access, NS 20 mL/kg bolus, ondansetron 0.15 mg/kg, methylprednisolone 1 mg/kg for severe episodes, dextrose if hypoglycemic, observe until clinically recovered (usually 4–6 hours)

— Investigational/specialty practice for persistent IgE-mediated milk allergy in older children

— Not standard Step 3 management for infants

— Allergist: IgE-mediated, FPIES, multiple food allergies, persistent symptoms

— Pediatric GI: enteropathy, eosinophilic disease, FTT, refractory cases

— Registered dietitian: ensure nutritional adequacy on restricted diet

— Lactation consultant: support continued breastfeeding during maternal elimination

CCS pearl: A vomiting, pale infant 2 hours after milk reintroduction during a home challenge → CCS orders: call EMS, IV access, NS bolus, ondansetron IV, continuous monitoring, admit for observation — and document FPIES diagnosis for outpatient allergy follow-up.

Board pearl: Always prescribe two epinephrine auto-injectors and a written anaphylaxis action plan for IgE-mediated CMPA patients before discharge.

CMPA is non-procedural; "procedures" in this topic are structured food challenges, endoscopy in atypical cases, and emergent resuscitation.

Supervised oral food challenge (OFC):

Endoscopy/colonoscopy with biopsy:

Acute resuscitation algorithms:

Oral immunotherapy (OIT):

Specialty referrals — Step 3 ambulatory thinking:

Special Populations — Comorbidity-Adjusted Considerations

— Increased gut permeability and immune immaturity → higher CMPA risk and overlap with necrotizing enterocolitis (NEC)

— Distinguish from NEC: NEC has pneumatosis intestinalis, systemic illness, abdominal distension; CMPA is more indolent

— Donor human milk preferred when mother's milk unavailable; avoid cow's milk–based fortifiers in suspected cases

— Hypoalbuminemia, edema, anemia → consider admission for nutritional rescue with amino acid formula via NG tube if intake inadequate

— Refeeding precautions in severely malnourished

— Monitor electrolytes, phosphorus, magnesium

— Older infant/toddler with feeding refusal, dysphagia, persistent vomiting on hydrolyzed formula

— Refer GI for endoscopy; treat with elemental formula or empiric food elimination diet

— Early CMPA + eczema increases risk for asthma, allergic rhinitis, additional food allergies

— Do not delay introduction of peanut in high-risk infants — LEAP trial supports introduction 4–6 months in eczema/egg allergy infants

— Risk of inadequate calcium, vitamin D, B12, iodine intake

— Supplement: calcium 1000 mg, vitamin D 600 IU

— Encourage continued breastfeeding — benefits outweigh elimination burden

— eHF and AAF are expensive; insurance/Medicaid often requires PA and documentation

— WIC may provide hypoallergenic formula with medical documentation

Step 3 management: A preterm 6-week-old (corrected) with bloody stools requires NEC workup first (abdominal radiograph, CBC, blood gas, blood culture) before attributing symptoms to CMPA — never anchor on allergy in a preterm infant without ruling out NEC.

Board pearl: Do not delay introduction of allergenic solids (peanut, egg) in CMPA infants — this paradoxically increases risk of additional food allergies per LEAP and EAT trial data.

Classic Step 3 "renal/hepatic adjustment" framing doesn't apply directly to infants with CMPA, but several adjacent populations require special handling:

Preterm infants:

Infants with severe failure to thrive:

Eosinophilic esophagitis (EoE) overlap:

Atopic march considerations:

Maternal considerations during dairy elimination:

Infants in WIC/food-insecure households:

Special Populations — Pediatric Subgroups and Atypical Presentations

— Most common Step 3 vignette

— Mother eliminates all cow's milk protein from her diet for 2–4 weeks

— If symptoms persist, add soy elimination; if still persistent, consider egg and other proteins

— Continue breastfeeding — this is essentially universal advice; weaning to formula is rarely necessary

— Switch to extensively hydrolyzed formula first; amino acid formula if no response in 2–4 weeks

— Avoid all dairy-containing solids (yogurt, cheese, baked goods with milk)

— Introduce other allergens (peanut, egg, wheat, tree nuts) on schedule

— Baked milk ladder: Some children with IgE-mediated CMPA tolerate baked milk (muffins, cakes) before fluid milk — confirms denatured casein tolerance and may accelerate resolution

— Performed under allergist supervision

— ~10% retain allergy; consider oral immunotherapy in specialty centers

— Comprehensive avoidance education, school 504 plan, epinephrine at school

— More common with non-IgE enteropathy and EoE

— Amino acid formula and dietitian-led elimination diet

— Many infant foods contain hidden milk (ghee, casein, whey, lactalbumin); educate families on label reading

— Plant-based "milks" (almond, oat, rice) are not nutritionally adequate substitutes for infant formula or whole milk in children <2 years

Key distinction: Baked milk tolerance (tolerating heat-denatured milk in baked goods) is a favorable prognostic marker for outgrowing IgE-mediated CMPA and is distinct from full milk tolerance — high-yield specialty pearl.

Board pearl: A 14-month-old with prior CMPA whose family is offering almond or rice milk as the primary beverage needs nutritional counseling — recommend continued breast milk, hypoallergenic toddler formula, or fortified soy milk (if no soy allergy) until tolerance is confirmed.

Exclusively breastfed infant with proctocolitis:

Mixed-fed and formula-fed infants:

Older infants (6–12 months) starting solids:

Toddlers with persistent CMPA:

Adolescents with persistent CMPA:

CMPA + multiple food allergies:

Cultural and dietary considerations:

Complications and Adverse Outcomes

— Failure to thrive from inadequate caloric intake during restrictive diets or untreated enteropathy

— Iron-deficiency anemia from chronic occult GI blood loss in proctocolitis or enteropathy

— Hypoalbuminemia, edema in protein-losing enteropathy

— Vitamin D and calcium deficiency from dairy avoidance — risk for rickets if unsupplemented

— Vitamin B12, zinc, iodine insufficiency in poorly designed elimination diets

— Linear growth faltering in chronic CMPA, particularly with delayed diagnosis or unnecessary continuation of restrictions

— Often catches up after appropriate dietary management

— Anaphylaxis in IgE-mediated CMPA — risk of death without prompt epinephrine

— FPIES shock — hypovolemia, methemoglobinemia, metabolic acidosis

— Dehydration from acute or chronic diarrhea/vomiting

— Maternal anxiety, breastfeeding cessation due to overly restrictive maternal diet

— Family stress, food cost, social meal restrictions

— School/daycare accommodation challenges in older children

— Unnecessary prolonged elimination when CMPA has resolved → nutritional restriction, missed window for tolerance development

— Inappropriate use of partially hydrolyzed or "sensitive" formulas → ongoing symptoms and delayed diagnosis

— Empiric universal soy substitution → 40–50% cross-reactivity in non-IgE CMPA

— Increased risk of asthma, allergic rhinitis, additional food allergies, atopic dermatitis persistence

Step 3 management: Always plan reintroduction trials at 9–12 months and again at 12–18 months for non-IgE CMPA; failure to reassess tolerance constitutes a quality-of-care gap and can result in unnecessary prolonged restriction, nutritional deficits, and delayed tolerance acquisition.

Board pearl: Rickets in an exclusively breastfed infant whose mother is on a dairy-free diet without vitamin D/calcium supplementation is a classic preventable complication — counsel maternal supplementation at every visit.

Nutritional complications:

Growth complications:

Acute complications:

Psychosocial and quality-of-life complications:

Iatrogenic complications:

Long-term atopic march:

When to Escalate Care — Consultation and Inpatient Triage

— Thriving infant with allergic proctocolitis

— Mild eczema with mild GI symptoms responsive to dietary changes

— Successful eHF or AAF trial with normal growth

— Any IgE-mediated reaction (urticaria, angioedema, wheeze, anaphylaxis)

— FPIES (for diagnosis confirmation and supervised future challenges)

— Multiple food allergies suspected

— Family history of severe atopic disease or anaphylaxis

— Planning oral food challenge or baked milk ladder

— Failure to thrive despite hypoallergenic formula

— Suspected eosinophilic esophagitis or gastroenteritis

— Persistent symptoms on amino acid formula

— Suspected IBD, celiac, or other GI pathology

— Anaphylaxis (observation ≥4–6 hours; longer if biphasic concern)

— Acute severe FPIES with shock, lethargy, or dehydration

— Severe failure to thrive requiring NG tube feeds or parenteral nutrition

— Severe protein-losing enteropathy with edema or electrolyte derangements

— Diagnostic uncertainty necessitating monitored food challenge

— Refractory anaphylaxis requiring epinephrine infusion

— FPIES shock unresponsive to initial fluids

— Severe metabolic acidosis or methemoglobinemia

— Registered dietitian: any infant on restricted diet

— Lactation consultant: support exclusive breastfeeding during maternal elimination

— Social work: food insecurity, formula access issues

CCS pearl: For an infant in anaphylactic shock from accidental milk exposure: IM epinephrine immediately, IV access, NS bolus 20 mL/kg, oxygen, continuous monitoring, H1/H2 blockers, methylprednisolone, observe ≥4–6 hours, allergy consult before discharge, prescribe two epinephrine auto-injectors, written action plan, schedule 1-week follow-up.

Board pearl: Anaphylaxis observation must be at least 4–6 hours to capture biphasic reactions (occur in up to 20%); discharge before this is a documented patient safety failure.

Outpatient management is appropriate for:

Indications for specialty referral (allergy/immunology):

Indications for GI referral:

Indications for hospital admission:

Indications for PICU:

Other consults:

Key Differentials — Same-Category (Allergic/GI) Causes

— Enzymatic (lactase deficiency), not immune

— Watery diarrhea, gas, bloating, abdominal pain — no blood, no eczema, no anaphylaxis

— Congenital form is rare; primary form develops after age 5; secondary form follows viral gastroenteritis

— Key distinction: Healthy term infant with bloody stool is almost never lactose intolerance

— Cross-reacts in 40–50% of FPIES; can be primary

— Same management principle: elimination and reintroduction

— Subset of non-IgE CMPA; can also be triggered by soy, rice, oat, chicken, fish

— Distinguishing feature: profuse vomiting 1–4 hours post-ingestion, pallor, lethargy

— Older infants/children with feeding difficulties, vomiting, dysphagia

— Endoscopy with ≥15 eosinophils/HPF

— Treated with elemental formula or empiric 6-food elimination

— Egg, peanut, tree nut, fish, shellfish, wheat

— Often coexist with CMPA

— Usually presents after gluten introduction (6+ months); FTT, diarrhea, abdominal distension

— Anti-tTG IgA with total IgA; biopsy confirms

— Allergic eosinophilic colitis in older children

— Eczema alone is not diagnostic of CMPA; many infants with eczema have no food trigger

Key distinction: Lactose intolerance vs CMPA — lactose intolerance has gas/diarrhea/bloating without blood, eczema, urticaria, or growth failure; CMPA is immune-mediated and frequently involves these features. Treatment also differs: lactose-free formula vs hydrolyzed/amino acid formula.

Board pearl: A "fussy" baby with normal growth and no blood, eczema, urticaria, or vomiting probably doesn't have CMPA — colic and gastroesophageal reflux are far more common and are wrong-answer traps when overdiagnosed as allergy.

Lactose intolerance:

Soy protein allergy:

Food protein-induced enterocolitis syndrome (FPIES):

Eosinophilic esophagitis/gastroenteritis:

IgE-mediated food allergy to other foods:

Celiac disease:

Other allergic GI conditions:

Atopic dermatitis without food allergy:

Key Differentials — Other-Category Causes

— Bacterial enteritis (Salmonella, Shigella, Campylobacter, E. coli O157:H7) — usually fever, ill appearance, often older infants

— C. difficile — recent antibiotics

— Rotavirus, norovirus — watery, not bloody

— Key distinction from CMPA: Infectious causes typically have fever and unwell appearance

— Anal fissure: Very common; bright red blood streaks on hard stool, visible on inspection

— Intussusception: "Currant jelly" stool, paroxysmal pain, palpable mass, age 6 months–2 years; emergent

— Meckel diverticulum: Painless brisk hematochezia in toddler; Meckel scan

— Volvulus, NEC, Hirschsprung enterocolitis: Ill-appearing infant with distension, bilious vomiting

— Recurrent regurgitation, irritability, often physiologic and self-limited

— Mimics CMPA but lacks blood, eczema, and improves with positional/feeding measures

— Projectile non-bilious vomiting in 3–6 week-old, palpable olive, hypochloremic metabolic alkalosis

— Distinguished by absence of allergic features and characteristic vomiting pattern

— Recurrent vomiting, lethargy, hypoglycemia, acidosis — newborn screen and metabolic workup

— Always on the differential for the lethargic, pale infant — FPIES classically masquerades as sepsis

— Rare in infancy; consider very-early-onset IBD (immunodeficiency-associated) in atypical, severe, refractory cases

— Late-onset (2–12 weeks) in exclusively breastfed infants without vitamin K prophylaxis

Key distinction: Anal fissure is by far the most common cause of bright red blood per rectum in infants — always inspect the anus before workup for CMPA; visible fissure with hard stool history changes management entirely (stool softening, hydration).

Board pearl: When an infant looks toxic with bilious vomiting, think surgical emergency (volvulus, intussusception, NEC) — not CMPA. Order an immediate abdominal radiograph and surgical consult.

Infectious causes of bloody stool/diarrhea:

Surgical/structural causes of bloody stool:

Gastroesophageal reflux disease (GERD):

Pyloric stenosis:

Inborn errors of metabolism:

Sepsis:

Inflammatory bowel disease:

Vitamin K deficiency bleeding:

Secondary Prevention, Discharge Planning, and Long-Term Care

— Confirmed diagnosis with elimination–reintroduction trial documented

— Formula prescription: extensively hydrolyzed or amino acid (with PA letter if needed)

— Maternal diet education with dietitian referral if breastfeeding

— Written symptom action plan with red-flag warning signs

— Two epinephrine auto-injectors prescribed (home + daycare/school)

— Anaphylaxis action plan in English and family's preferred language

— Medical alert identification (bracelet)

— Daycare/school staff training on epinephrine use

— Allergist follow-up every 6–12 months with serial specific IgE

— Strict avoidance during active disease

— Plan reintroduction: proctocolitis around 9–12 months; FPIES at 12–18 months (supervised); IgE-mediated at 12 months with falling sIgE (supervised challenge)

— Exclusive breastfeeding for first 4–6 months (does not prevent CMPA but recommended)

— Early introduction of allergenic solids (peanut, egg) at 4–6 months in high-risk infants per LEAP/EAT guidance

— Routine cow's milk formula introduction is NOT delayed for prevention

— Maternal dietary restriction during pregnancy/lactation is not recommended for prevention

— Hydrolyzed formulas for prevention: evidence weak; not routinely recommended

— Monitor growth, nutrition, atopic comorbidities (asthma, eczema, rhinitis)

— Vitamin D 400 IU daily for all breastfed infants

— Vaccinations: MMR and rotavirus are safe in CMPA (rotavirus vaccine traces of bovine protein are negligible — not a contraindication)

Step 3 management: Before discharging an infant with confirmed IgE-mediated CMPA, ensure: (1) two epinephrine auto-injectors, (2) written anaphylaxis action plan, (3) allergist appointment within 4–6 weeks, (4) pediatrician follow-up in 1–2 weeks, (5) dietitian referral, (6) family education documented.

Board pearl: Delaying introduction of peanut/egg in an infant with CMPA increases the risk of additional food allergies — a classic LEAP-trial-era teaching point.

Discharge planning after acute CMPA presentation:

For IgE-mediated CMPA:

For non-IgE CMPA (proctocolitis, FPIES, enteropathy):

Primary prevention in siblings/high-risk infants:

Long-term considerations:

Follow-Up, Monitoring Parameters, and Counseling

— Initial diagnosis: 1–2 weeks to assess response to dietary change

— 4–6 weeks: confirm symptom resolution, growth trajectory

— Every 2–3 months during first year: weight, length, head circumference, nutritional assessment

— Reintroduction trials at 9–12 months and 12–18 months as appropriate by phenotype

— Every 6–12 months with serial specific IgE measurements

— Skin prick testing periodically to track sensitization

— Supervised oral food challenges when criteria met (typically decreasing sIgE, age >12 months, no recent reactions)

— Growth: Plot at every visit; declining percentiles trigger escalation

— Nutritional adequacy: Caloric intake, iron, vitamin D, calcium, zinc, B12

— Stool patterns: Resolution of blood, consistency, frequency

— Eczema severity: SCORAD or visual assessment

— Family adherence and quality of life

— Label reading: "contains milk" allergen statement; hidden sources (whey, casein, lactalbumin, ghee, caseinate, nougat)

— Cross-contamination at restaurants, daycare, family events

— Travel preparation: epinephrine availability, action plan, language cards

— School/daycare communication: 504 plans, individualized health plans

— Avoiding overly restrictive maternal diets — only eliminate proteins with documented reactions

— Reassurance that most non-IgE CMPA resolves by age 1; most IgE-mediated by age 5

— Reintroduction timing based on phenotype severity

— Baked milk ladder if appropriate

— Avoid unsupervised challenges in IgE-mediated or FPIES cases

Step 3 management: For a thriving 9-month-old with prior proctocolitis on a maternal dairy-free diet, trial reintroduction of dairy into the maternal diet (and small amounts into the infant's diet); if no recurrence over 2–4 weeks, tolerance is established and unrestricted diet can resume.

Board pearl: Repeated growth measurements plotted on standardized curves are the single most important monitoring tool in CMPA — both to confirm dietary therapy adequacy and to flag failure to thrive requiring escalation.

Pediatric primary care follow-up cadence:

Allergist follow-up (IgE-mediated/FPIES):

Monitoring parameters:

Counseling priorities:

Anticipatory guidance for tolerance development:

Ethical, Legal, and Patient Safety Considerations

— Discuss risks (anaphylaxis, FPIES reaction), benefits (confirming tolerance, lifting restrictions), and alternatives

— Document in writing; have emergency medications and IV access ready

— Postpone if intercurrent illness, asthma exacerbation, or recent vaccination

— Caregiver-imposed extreme dietary restriction (e.g., infant fed only rice milk or homemade "formula") causing failure to thrive may constitute medical neglect — mandatory CPS reporting in most US states

— Munchausen by proxy/factitious disorder imposed on another: parents claiming severe food allergies without objective evidence to obtain medical attention — requires careful documentation and possible CPS consultation

— Communication failures between PCP, allergist, GI, and daycare/school

— Action plan must travel with the patient — copies at home, daycare, school, grandparents

— Refilling epinephrine before expiration (every 12–18 months); document refills in the chart

— Daycare staff training and emergency drills

— MMR vaccine is safe in egg-allergic and milk-allergic patients

— Rotavirus vaccine is safe in CMPA despite trace bovine protein

— Counsel families to avoid vaccine refusal driven by misinformation

— Hypoallergenic formulas cost $40–60+ per can; insurance prior authorization often required

— Document growth failure, eHF trial, and clinical need for AAF coverage

— WIC may provide hypoallergenic formula with medical documentation

— Advocate for families navigating insurance denials — a Step 3 health-systems responsibility

— Diagnosing CMPA where it doesn't exist subjects mothers and infants to unnecessary dietary restrictions, increases healthcare costs, and may delay correct diagnoses (e.g., GERD, colic, infection)

— Use rigorous elimination–reintroduction methodology

Step 3 management: When parents refuse standard infant formula and feed an infant unfortified homemade nut milk leading to failure to thrive, the physician's obligation is to (1) educate, (2) provide medically appropriate alternatives, (3) document interventions, and (4) file a CPS report if neglect persists and the child remains at risk — this is mandatory reporting territory.

Board pearl: Rotavirus vaccination is not contraindicated in CMPA — refusing to administer it is the wrong answer.

Informed consent for oral food challenges:

Mandatory reporting and child welfare concerns:

Transition-of-care risks (high-yield Step 3 theme):

Vaccination ethics and safety:

Equity and access issues:

Avoiding overdiagnosis:

High-Yield Associations and Rapid-Fire Clinical Facts

Board pearl: Memorize the eHF → AAF stepwise escalation for formula-fed CMPA infants — this sequence is tested repeatedly.

Key distinction: IgE-mediated CMPA = immediate, skin/respiratory, IgE testing useful; non-IgE CMPA = delayed, GI-predominant, testing not useful, diagnosis is clinical.

Most common food allergy in infancy: Cow's milk protein.

Most common presentation: Allergic proctocolitis — thriving breastfed infant with blood-streaked stools.

First-line formula for CMPA: Extensively hydrolyzed (casein-based) — tolerated by ~90%.

Second-line formula: Amino acid–based (after eHF failure or severe cases).

Formulas that are NOT therapeutic: Partially hydrolyzed, "sensitive," "comfort," goat/sheep milk.

Soy formula cross-reactivity in FPIES: Up to 40–50% — avoid empirically.

MMR/rotavirus vaccines: Safe in CMPA.

Natural history: 50% tolerate by age 1, 75% by age 3, >90% by age 5 (IgE-mediated lasts longer).

Maternal supplementation during dairy elimination: Calcium 1000 mg, vitamin D 600 IU.

Infant vitamin D supplementation: 400 IU/day for all breastfed infants.

Epinephrine auto-injector dosing: 0.15 mg for <25 kg, 0.3 mg for ≥25 kg.

Anaphylaxis observation period: ≥4–6 hours (biphasic risk up to 20%).

FPIES classic presentation: Profuse vomiting 1–4 hours post-ingestion, pallor, lethargy, NO fever, NO urticaria.

FPIES treatment: IV fluids 20 mL/kg, ondansetron, methylprednisolone for severe episodes.

Atopic march: CMPA + eczema increases risk of asthma, allergic rhinitis, more food allergies.

LEAP trial implication: Early introduction (4–6 months) of peanut/egg in high-risk infants reduces additional food allergy.

NOT a treatment for CMPA: Probiotics, lactase drops, food-specific IgG panels.

NOT a prevention strategy: Maternal dietary restriction during pregnancy.

Anal fissure is the most common cause of bright red blood per rectum in well infants — always examine.

Reintroduction timing: Proctocolitis ~9–12 months; FPIES at 12–18 months supervised; IgE-mediated at 12+ months with falling sIgE supervised.

Baked milk tolerance in IgE-mediated CMPA is a favorable prognostic sign.

Cow's milk should NOT be used as a primary beverage before age 12 months (anemia, GI bleeding even in non-allergic infants).

Goat and sheep milk: Extensively cross-reactive with bovine milk — not safe substitutes.

Board Question Stem Patterns

— "A 6-week-old exclusively breastfed infant has streaks of blood and mucus in otherwise normal stool. Weight gain is appropriate. Exam is normal."

— Best next step: Maternal elimination of cow's milk protein for 2–4 weeks.

— Wrong answers: endoscopy, stool cultures, switch to soy formula, switch to lactose-free formula.

— "A 5-month-old previously breastfed develops urticaria, lip swelling, and wheezing 15 minutes after first cow's milk formula bottle."

— First step: IM epinephrine 0.01 mg/kg into anterolateral thigh.

— Wrong answers: oral diphenhydramine, IV steroids, observation only, switching to soy formula first.

— "A 4-month-old becomes lethargic and pale with repetitive vomiting 2 hours after switching to cow's milk formula. Afebrile. No rash."

— Diagnosis: Acute FPIES.

— Management: IV fluids, ondansetron, methylprednisolone for severe; avoid empiric antibiotics if FPIES is clear; switch to extensively hydrolyzed or amino acid formula.

— "Despite extensively hydrolyzed formula for 4 weeks, infant continues to have bloody stools and is now <3rd percentile weight."

— Next step: Switch to amino acid–based formula and refer to pediatric GI.

— "A nursing mother eliminating all dairy asks about supplementation."

— Answer: Calcium 1000 mg/day and vitamin D 600 IU/day; continue breastfeeding.

— "Should a 6-month-old with CMPA receive MMR or rotavirus vaccine?"

— Answer: Yes — neither is contraindicated.

— "A 10-month-old previously diagnosed with allergic proctocolitis at 6 weeks has been asymptomatic on maternal elimination diet."

— Next step: Trial reintroduction of dairy into maternal diet; monitor for symptom recurrence.

— "An infant with FPIES to cow's milk is being switched to formula."

— Best choice: Extensively hydrolyzed casein formula; avoid soy due to cross-reactivity.

— Food-specific IgG panels, probiotics as treatment, partial hydrolysate formulas, goat milk, prolonged antibiotic courses, restricting maternal diet during pregnancy.

Board pearl: When the stem describes a thriving infant with isolated blood in stool, resist the urge to order endoscopy, stool cultures, or extensive labs — the answer is dietary modification.

Stem pattern 1 — Classic proctocolitis:

Stem pattern 2 — Anaphylaxis after first formula bottle:

Stem pattern 3 — FPIES mimicking sepsis:

Stem pattern 4 — Failed eHF trial:

Stem pattern 5 — Maternal dairy elimination question:

Stem pattern 6 — Vaccination question:

Stem pattern 7 — Reintroduction timing:

Stem pattern 8 — Cross-reactivity trap:

Stem pattern 9 — Wrong-answer distractors:

One-Line Recap

Cow's milk protein allergy is an immune-mediated reaction (IgE, non-IgE, or mixed) most commonly presenting as a thriving breastfed infant with blood-streaked stools (allergic proctocolitis), confirmed by elimination and reintroduction, and managed first-line with maternal dairy elimination if breastfed or extensively hydrolyzed formula (escalating to amino acid formula) if formula-fed — with most cases resolving by age 1–3 years.

Board pearl: The single most testable Step 3 vignette is the thriving breastfed infant with bloody stools whose mother should eliminate dairy — not endoscopy, not formula switch, not stool cultures, not soy.

High-yield diagnostic anchor: CMPA is a clinical diagnosis confirmed by elimination–reintroduction; specific IgE and skin testing inform IgE-mediated cases only and do not exclude non-IgE disease. Food-specific IgG panels have no role.

High-yield therapeutic anchor: Stepwise feeding strategy — maternal elimination (continue breastfeeding) → extensively hydrolyzed formula → amino acid formula. Avoid soy in FPIES/non-IgE due to cross-reactivity; avoid goat/sheep milk universally; partially hydrolyzed formulas are not therapeutic.

High-yield acute management anchor: IM epinephrine first for anaphylaxis (auto-injector at home, two devices, action plan); for FPIES — IV fluids, ondansetron, methylprednisolone, observation, and avoid mistaking for sepsis. Observe anaphylaxis at least 4–6 hours for biphasic reactions.

High-yield longitudinal anchor: Most non-IgE CMPA resolves by age 1; plan reintroduction trials at 9–12 months (proctocolitis), 12–18 months supervised (FPIES), and at 12+ months with falling sIgE (IgE-mediated). Monitor growth at every visit, supplement vitamin D and calcium in mothers and infants, do not delay peanut/egg introduction (LEAP), and ensure MMR and rotavirus vaccines are administered on schedule — they are not contraindicated.